Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes

被引:59
作者
Barbanti, P
Fabbrini, G
Ricci, A
Pascali, MP
Bronzetti, E
Amenta, F
Lenzi, GL
Cerbo, R
机构
[1] Univ La Sapienza, Dept Neurosci, I-00185 Rome 1, Italy
[2] Univ La Sapienza, Dept Cardiovasc & Resp Sci, I-00185 Rome, Italy
[3] Univ Camerino, Dept Pharmacol Sci & Expt Med, Sect Human Anat, I-62032 Camerino, Italy
关键词
migraine; dopamine receptors; lymphocytes; D-3; receptor; D-4;
D O I
10.1046/j.1468-2982.2000.00001.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies have revealed peculiar functional and genetic features of dopamine receptors in migraine. As peripheral blood lymphocytes (PBL) may represent a tool for peripheral detection of neuroreceptors, we compared the expression of dopamine D3 (DRD3) and D4 (DRD4) receptors on PBL in migraine patients and in healthy controls using radioligand binding assay techniques in the presence of antidopamine D2-like receptor antibodies. The dopamine D2-like receptor agonist [H-3]7-OH-DPAT was used as a radioligand. An increased density of both DRD3 (P=0.0006) and DRD4 (P=0.002) on PBL was observed in migraineurs compared with controls. This up-regulation might reflect central and/or peripheral dopamine receptor hypersensitivity due to hypofunction of the dopaminergic system. These findings support the view that dopamine D2-like receptors are involved in the determination of the so-called migraine trait, which may help to elucidate several clinical features of the disease.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 39 条
[31]   MOLECULAR-BIOLOGY OF DOPAMINE-RECEPTORS [J].
SIBLEY, DR ;
MONSMA, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (02) :61-69
[32]   FLUNARIZINE IN PROPHYLAXIS OF CHILDHOOD MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY [J].
SORGE, F ;
DESIMONE, R ;
MARANO, E ;
NOLANO, M ;
OREFICE, G ;
CARRIERI, P .
CEPHALALGIA, 1988, 8 (01) :1-6
[33]  
STANISZ AM, 1987, J IMMUNOL, V139, P749
[34]   HUMAN PERIPHERAL-BLOOD LYMPHOCYTES EXPRESS D5 DOPAMINE RECEPTOR GENE AND TRANSCRIBE THE 2 PSEUDOGENES [J].
TAKAHASHI, N ;
NAGAI, Y ;
UENO, S ;
SAEKI, Y ;
YANAGIHARA, T .
FEBS LETTERS, 1992, 314 (01) :23-25
[35]   HIGH-AFFINITY BINDING-SITES FOR NEUROLEPTIC DRUGS IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES AND THEIR RELATION TO DOPAMINE-RECEPTORS - A LONG-STANDING CONTROVERSY [J].
VILE, JM ;
STRANGE, PG .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (06) :747-753
[36]  
WALLACE DR, 1995, J NEUROCHEM, V64, P700
[37]   BINDING OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) BY HUMAN-BLOOD MONOCYTES - DEMONSTRATION OF SPECIFIC BINDING-SITES [J].
WIIK, P ;
OPSTAD, PK ;
BOYUM, A .
REGULATORY PEPTIDES, 1985, 12 (02) :145-153
[38]   BETA-ADRENOCEPTOR EXPRESSION ON CIRCULATING MONONUCLEAR-CELLS OF IDIOPATHIC PARKINSONS-DISEASE AND AUTONOMIC FAILURE PATIENTS BEFORE AND AFTER REDUCTION OF CENTRAL SYMPATHETIC OUTFLOW BY CLONIDINE [J].
ZOUKOS, Y ;
THOMAIDES, T ;
PAVITT, DV ;
CUZNER, ML ;
MATHIAS, CJ .
NEUROLOGY, 1993, 43 (06) :1181-1187
[39]  
ENKEPHALINS ENDORPHI